CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis

PLoS ONE

Volumn 12, Issue 8, 2017, Pages

  Müller, Irene ^a,b   Pappritz, Kathleen ^a,b   Savvatis, Konstantinos ^c,d   Puhl, Kerstin ^a   Dong, Fengquan ^a   El Shafeey, Muhammad ^a   Hamdani, Nazha ^e   Hamann, Isabell ^a   Noutsias, Michel ^f   Infante Duarte, Carmen ^a   Linke, Wolfgang A ^e   Van Linthout, Sophie ^a,b   Tschöpe, Carsten ^a,b  

^a BERLIN INSTITUTE OF HEALTH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, MOUSE; CX3CR1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; PROTEIN KINASE; TITIN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CCR2 GENE; CELL INFILTRATION; CONTROLLED STUDY; COXSACKIEVIRUS B3; CX3CL1 GENE; CX3CR1 GENE; DISEASE SEVERITY; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; MCP 1 GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS MYOCARDITIS; ANIMAL; C57BL MOUSE; COXSACKIE VIRUS INFECTION; DEFICIENCY; DISEASE MODEL; ENTEROVIRUS B; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART FUNCTION TEST; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MYOCARDITIS; PATHOGENICITY; PATHOLOGY; PHOSPHORYLATION; VIROLOGY;

ANIMALS; APOPTOSIS; CELL ADHESION MOLECULES; CHEMOKINE CX3CL1; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; GENE EXPRESSION REGULATION; HEART FUNCTION TESTS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASES; RECEPTORS, CHEMOKINE;

EID: 85027269547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0182643     Document Type: Article

References (48)

1. Gui J, Yue Y, Chen R, Xu W, Xiong S (2012) A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-kappaB signaling. PLoS One 7: e46515. https://doi.org/10.1371/journal.pone.0046515 PMID: 23029542
2. Van Linthout S, Savvatis K, Miteva K, Peng J, Ringe J, et al. (2011) Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 32: 2168–2178. https://doi.org/10.1093/eurheartj/ehq467 PMID: 21183501
3. Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60: 5–10. PMID: 14522402
4. Van Linthout S, Tschope C, Schultheiss HP (2014) Lack in treatment options for virus-induced inflammatory cardiomyopathy: can iPS-derived cardiomyocytes close the gap? Circ Res 115: 540–541. https://doi.org/10.1161/CIRCRESAHA.114.304951 PMID: 25170089
5. Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. (2016) The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J Am Coll Cardiol 68: 2348–2364. https://doi.org/10.1016/j.jacc.2016.09.937 PMID: 27884253
6. Frangogiannis NG, Entman ML (2004) Targeting the chemokines in myocardial inflammation. Circulation 110: 1341–1342. https://doi.org/10.1161/01.CIR.0000141560.18364.63 PMID: 15364818
7. Shen Y, Xu W, Chu YW, Wang Y, Liu QS, et al. (2004) Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 78: 12548–12556. https://doi.org/10.1128/JVI.78.22.12548-12556.2004 PMID: 15507642
8. Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H (2000) Role of MIP-2 in coxsackievirus B3 myocarditis. J Mol Cell Cardiol 32: 631–638. https://doi.org/10.1006/jmcc.2000.1102 PMID: 10756119
9. Escher F, Vetter R, Kuhl U, Westermann D, Schultheiss HP, et al. (2011) Fractalkine in human inflammatory cardiomyopathy. Heart 97: 733–739. https://doi.org/10.1136/hrt.2010.205716 PMID: 21357373
10. Vitale S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet MA, et al. (2004) Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol 172: 585–592. PMID: 14688370
11. Green SR, Han KH, Chen Y, Almazan F, Charo IF, et al. (2006) The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J Immunol 176: 7412–7420. PMID: 16751386
12. Altin SE, Schulze PC (2011) Fractalkine: a novel cardiac chemokine? Cardiovasc Res 92: 361–362. https://doi.org/10.1093/cvr/cvr272 PMID: 22012953
13. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, et al. (2001) Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 79: 298–302. https://doi.org/10.1046/j.1440-1711.2001.01004.x PMID: 11380684
14. Damas JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, et al. (2000) Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res 47: 778–787. PMID: 10974226
15. Husberg C, Nygard S, Finsen AV, Damas JK, Frigessi A, et al. (2008) Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol 45: 261–269. https://doi.org/10.1016/j.yjmcc.2008.05.009 PMID: 18585734
16. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO (2002) Fractalkine expression in human renal inflammation. J Pathol 196: 85–90. https://doi.org/10.1002/path.1010 PMID: 11748646
17. Umehara H, Tanaka M, Sawaki T, Jin ZX, Huang CR, et al. (2006) Fractalkine in rheumatoid arthritis and allied conditions. Mod Rheumatol 16: 124–130. https://doi.org/10.1007/s10165-006-0471-9 PMID: 16767549
18. Robinson LA, Nataraj C, Thomas DW, Howell DN, Griffiths R, et al. (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165: 6067–6072. PMID: 11086038
19. Gu X, Xu J, Yang XP, Peterson E, Harding P (2015) Fractalkine neutralization improves cardiac function after myocardial infarction. Exp Physiol 100: 805–817. https://doi.org/10.1113/EP085104 PMID: 25943588
20. Poupel L, Boissonnas A, Hermand P, Dorgham K, Guyon E, et al. (2013) Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33: 2297–2305. https://doi.org/10.1161/ATVBAHA.112.300930 PMID: 23887641
21. Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, et al. (2010) The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52: 1769–1782. https://doi.org/10.1002/hep.23894 PMID: 21038415
22. Feng X, Szulzewsky F, Yerevanian A, Chen Z, Heinzmann D, et al. (2015) Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Oncotarget 6: 15077–15094. https://doi.org/10.18632/oncotarget.3730 PMID: 25987130
23. Hertwig L, Hamann I, Romero-Suarez S, Millward JM, Pietrek R, et al. (2016) CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation. Eur J Immunol 46: 1984–1996. https://doi.org/10.1002/eji.201546194 PMID: 27325505
24. Savvatis K, van Linthout S, Miteva K, Pappritz K, Westermann D, et al. (2012) Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLoS One 7: e41047. https://doi.org/10.1371/journal.pone.0041047 PMID: 22815907
25. Noutsias M, Pauschinger M, Ostermann K, Escher F, Blohm JH, et al. (2002) Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 8: MT59–71. PMID: 12011783
26. Hamdani N, Krysiak J, Kreusser MM, Neef S, Dos Remedios CG, et al. (2013) Crucial role for Ca2 (+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res 112: 664–674. https://doi.org/10.1161/CIRCRESAHA.111.300105 PMID: 23283722
27. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, et al. (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4: 44–52. https://doi.org/10.1161/CIRCHEARTFAILURE.109.931451 PMID: 21075869
28. Linke WA, Hamdani N (2014) Gigantic business: titin properties and function through thick and thin. Circ Res 114: 1052–1068. https://doi.org/10.1161/CIRCRESAHA.114.301286 PMID: 24625729
29. Spillmann F, Graiani G, Van Linthout S, Meloni M, Campesi I, et al. (2006) Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium. Regen Med 1: 235–254. https://doi.org/10.2217/17460751.1.2.235 PMID: 17465807
30. Leri A, Claudio PP, Li Q, Wang X, Reiss K, et al. (1998) Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 101: 1326–1342. https://doi.org/10.1172/JCI316 PMID: 9525975
31. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, et al. (1998) Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97: 194–203. PMID: 9445173
32. Van Linthout S, Spillmann F, Riad A, Trimpert C, Lievens J, et al. (2008) Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. Circulation 117: 1563–1573. https://doi.org/10.1161/CIRCULATIONAHA.107.710830 PMID: 18332268
33. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, et al. (2000) Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6: 693–697. https://doi.org/10.1038/76277 PMID: 10835688
34. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, et al. (1997) Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158: 1825–1832. PMID: 9029122
35. Menasria R, Canivet C, Piret J, Gosselin J, Boivin G (2016) Protective Role of CX3CR1 Signaling in Resident Cells of the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis. J Gen Virol.
36. Miteva K, Pappritz K, El-Shafeey M, Dong F, Ringe J, et al. (2017) Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis. Stem Cells Transl Med 6: 1249–1261. https://doi.org/10.1002/sctm.16-0353 PMID: 28186704
37. Li YC, Ge LS, Yang PL, Tang JF, Lin JF, et al. (2010) Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction. Eur J Pharmacol 640: 112–116. https://doi.org/10.1016/j.ejphar.2010.04.037 PMID: 20457150
38. Tada Y, Suzuki J (2016) Oxidative stress and myocarditis. Curr Pharm Des 22: 450–471. PMID: 26696256
39. Kojima A, Matsumoto A, Nishida H, Reien Y, Iwata K, et al. (2015) A protective role of Nox1/NADPH oxidase in a mouse model with hypoxia-induced bradycardia. J Pharmacol Sci 127: 370–376. https://doi.org/10.1016/j.jphs.2015.02.007 PMID: 25837936
40. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, et al. (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41: 2164–2171. PMID: 12821241
41. Lee J, Bae EH, Ma SK, Kim SW (2016) Altered Nitric Oxide System in Cardiovascular and Renal Diseases. Chonnam Med J 52: 81–90. https://doi.org/10.4068/cmj.2016.52.2.81 PMID: 27231671
42. Engel DR, Krause TA, Snelgrove SL, Thiebes S, Hickey MJ, et al. (2015) CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J Immunol 194: 1628–1638. https://doi.org/10.4049/jimmunol.1402149 PMID: 25595779
43. Aoyama T, Inokuchi S, Brenner DA, Seki E (2010) CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52: 1390–1400. https://doi.org/10.1002/hep.23795 PMID: 20683935
44. Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579–591. https://doi.org/10.1016/j.immuni.2007.03.014 PMID: 17481928
45. Grotendorst GR, Smale G, Pencev D (1989) Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 140: 396–402. https://doi.org/10.1002/jcp.1041400226 PMID: 2745570
46. Van Linthout S, Miteva K, Tschope C (2014) Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 102: 258–269. https://doi.org/10.1093/cvr/cvu062 PMID: 24728497
47. Kimura A (2016) Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet 61: 41–50. https://doi.org/10.1038/jhg.2015.83 PMID: 26178429
48. Radke MH, Peng J, Wu Y, McNabb M, Nelson OL, et al. (2007) Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci U S A 104: 3444–3449. https://doi.org/10.1073/pnas.0608543104 PMID: 17360664